|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 |
c.4096+7G>A |
IVS11+7G>A |
- |
0.082568807 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
4.41 |
- |
- |
- |
4.41 |
- |
BRCA1_00437 |
11 |
c.4096+27C>T |
IVS11+27C>T |
- |
0.481283422 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.03 |
- |
- |
- |
- |
- |
30 |
- |
BRCA1_00436 |
11 |
c.4097-164T>C |
IVS11-164T>C |
- |
0.008097166 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.4 |
- |
- |
- |
0.4 |
- |
BRCA1_00440 |
11 |
c.4097-10G>A |
IVS11-10G>A |
- |
0.000573213 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.0113225 |
1.215721465 |
- |
0.013765006 |
- |
BRCA1_00681 |
11 |
c.4097-2A>G |
IVS12-2A>G |
- |
0.992684781 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
0.4203 |
9.9856 |
- |
- |
- |
4.19694768 |
- |
BRCA1_00342 |
12 |
c.4097-15T>C (Reported 2 times) |
IVS11-15T>C |
- |
0.131 |
3 - Uncertain |
Thomassen et al. 2012 |
Vallee et al. 2016 |
- |
0.04 |
0.00 |
0.04 |
3.44 |
- |
- |
1.05 |
- |
3.61 |
- |
BRCA1_00149 |
12 |
c.4097-11T>C |
IVS11-11T>C |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.04 |
0.00 |
0.04 |
1 |
- |
0.43 |
3.55E-03 |
- |
1.51E-03 |
- |
BRCA1_00137 |
12 |
c.4097-1G>A |
IVS11-1G>A |
- |
0.999 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
22.91 |
1.02 |
- |
23.44 |
- |
BRCA1_00136 |
12 |
c.4103C>T |
4222C>T |
p.A1368G |
0.001629992 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.08 |
- |
- |
- |
0.08 |
- |
BRCA1_00442 |
12 |
c.4111G>C |
4230G>C |
p.G1371R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.455675089 |
1.102597599 |
- |
1.605023858 |
- |
BRCA1_00443 |
12 |
c.4115G>A |
4234G>A |
p.C1372Y |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.3 |
- |
- |
0.443076314 |
1.1390848 |
- |
0.504701494 |
- |
BRCA1_00683 |
12 |
c.4127C>G |
4246C>G |
p.T1376R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.452648414 |
1.176779436 |
- |
0.532667346 |
- |
BRCA1_00445 |
12 |
c.4131C>A |
4250C>A |
p.S1377R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.033092037 |
- |
0.805513149 |
- |
BRCA1_00446 |
12 |
c.4132G>A |
4251G>A |
p.V1378I |
2.60554E-05 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.0443 |
0.041556378 |
0.425576634 |
1.629615745 |
- |
0.001276746 |
- |
BRCA1_00447 |
12 |
c.4184A>G |
4303A>G |
p.Q1395R |
0.015735369 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
- |
- |
0.027244197 |
1.1390848 |
- |
0.03103345 |
- |
BRCA1_00448 |
12 |
c.4184_4185+2del |
4303_4304+2del |
- |
0.986 |
4 - Likely pathogenic |
Thomassen et al. 2012 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
2.09 |
- |
- |
1.05 |
- |
2.19 |
- |
BRCA1_00150 |
12 |
c.4185G>A |
4304G>A |
p.Q1395Q |
0.999943463 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.02 |
0.97 |
0.02 |
0.97 |
39.31669401 |
13.9129 |
- |
- |
- |
547.0092321 |
- |
BRCA1_00361 |
12 |
c.4185+1G>T |
IVS12+1G>T |
- |
0.989476056 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
2.637298196 |
1.102597599 |
- |
2.907878658 |
- |
BRCA1_00451 |
12 |
c.4185+2_4185+22delinsA |
IVS12+2del21insA |
- |
0.999913731 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
0.325512345 |
30.64568 |
28.61203126 |
1.255952165 |
- |
358.4747047 |
- |
BRCA1_00452 |
12 |
c.4185_4185+3del |
4304del4 |
- |
0.986076369 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
2.09 |
- |
- |
1.048 |
- |
2.19032 |
- |
BRCA1_00354 |
12 |
c.4185+5_4185+7del |
IVS12+5del3 |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.04 |
- |
- |
0.488988382 |
1.033092037 |
- |
0.505170003 |
- |
BRCA1_00454 |
12 |
c.4185+9C>T |
IVS12+9C>T |
- |
0.001394135 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
0.2012 |
0.34 |
- |
- |
- |
0.068408 |
- |
BRCA1_00684 |
12 |
c.4185+10G>C |
IVS12+10G>C |
- |
0.000128868 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
0.51 |
0.336129918 |
0.036840044 |
- |
0.006315351 |
- |
BRCA1_00450 |
12 |
c.4185+30G>A |
IVS12+30G>A |
- |
0.050387597 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
2.6 |
- |
- |
- |
2.6 |
- |
BRCA1_00453 |
12 |
c.4186-19C>G |
IVS12-19C>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
0.893504299 |
1.033092037 |
- |
0.923072177 |
- |
BRCA1_00459 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
12 |
c.4186-19C>T |
IVS12-19C>T |
- |
0.00763887 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.173098209 |
1.067279157 |
- |
0.184744111 |
- |
BRCA1_00460 |
12 |
c.4186-11C>T |
IVS12-11C>T |
- |
0.162101679 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.363514885 |
1.033092037 |
- |
0.375544333 |
- |
BRCA1_00458 |
12 |
c.4186-10G>A |
IVS12-10G>A |
- |
0.015233194 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.02469952 |
1.215721465 |
- |
0.030027737 |
- |
BRCA1_00685 |
13 |
c.4199T>C |
4318T>C |
p.M1400T |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.902722674 |
1.033092037 |
- |
1.965687644 |
- |
BRCA1_00461 |
13 |
c.4204C>T |
4323C>T |
p.H1402Y |
0.00012 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1.95 |
- |
0.851 |
0.00355 |
- |
0.00589 |
- |
BRCA1_00085 |
13 |
c.4205A>G |
4324A>G |
p.H1402R |
0.057042215 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
2.869202485 |
1.033092037 |
- |
2.96415024 |
- |
BRCA1_00462 |
13 |
c.4211T>C |
4330T>C |
p.L1404P |
0.095593267 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
4.852679085 |
1.067279157 |
- |
5.179163244 |
- |
BRCA1_00463 |
13 |
c.4213A>G |
4332A>G |
p.I1405V |
0.001564304 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.3 |
- |
0.148 |
0.383841549 |
0.034517721 |
1.864327003 |
0.003655762 |
- |
BRCA1_00464 |
13 |
c.4255G>C |
4374G>C |
p.E1419Q |
0.00073 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.13 |
0.00 |
0.13 |
1 |
- |
0.00427 |
1.15 |
- |
0.00491 |
- |
BRCA1_00086 |
13 |
c.4261C>T |
4380C>T |
p.H1421D |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.1496 |
3.191474402 |
1.1390848 |
- |
0.543849853 |
- |
BRCA1_00465 |
13 |
c.4262A>G |
4381A>G |
p.H1421R |
0.005074123 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.212359312 |
1.176779436 |
- |
0.249900071 |
- |
BRCA1_00466 |
13 |
c.4288C>T |
4407C>T |
p.P1430A |
0.00532968 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.254143535 |
1.033092037 |
- |
0.262553663 |
- |
BRCA1_00467 |
13 |
c.4327C>G |
4446C>G |
p.R1443G |
2.2324E-06 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.05045792 |
0.16 |
0.007065452 |
1.917698298 |
- |
0.000109388 |
- |
BRCA1_00469 |
13 |
c.4328G>A |
4447G>A |
p.R1443Q |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.187469041 |
1.033092037 |
- |
1.226764811 |
- |
BRCA1_00470 |
13 |
c.4342A>G |
4461A>G |
p.S1448G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.6395 |
3.73 |
0.225883846 |
1.176779436 |
- |
1.625550617 |
- |
BRCA1_00471 |
13 |
c.4357+1G>A |
IVS13+1G>A |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
1.23E+06 |
3.98 |
- |
4.90E+06 |
- |
BRCA1_00138 |
13 |
c.4357+1G>T |
IVS13+1G>T |
- |
0.993968273 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
0.67480032 |
- |
6.630542421 |
1.1390848 |
- |
5.096598175 |
- |
BRCA1_00363 |
13 |
c.4357+6T>C |
IVS13+6T>C |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
1.687900947 |
1.033092037 |
- |
1.743757028 |
- |
BRCA1_00371 |
13 |
c.4358-2del |
IVS13-2delA |
- |
- |
- |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.34 |
- |
- |
- |
1.034 |
- |
1.034 |
- |
BRCA1_00687 |
14 |
c.4402A>C |
4521A>C |
p.N1468H |
0.00006 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.912 |
0.00324 |
- |
0.00295 |
- |
BRCA1_00087 |
14 |
c.4410A>T |
4529A>T |
p.E1470E |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.586165284 |
1.430636021 |
- |
0.838589169 |
- |
BRCA1_00477 |
14 |
c.4454C>T |
4573C>T |
p.T1485S |
0.105707369 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
5.606381896 |
1.033092037 |
- |
5.791908494 |
- |
BRCA1_00479 |
14 |
c.4479_4484+2dup (Reported 2 times) |
4598_4603+2dup |
- |
0.988 |
4 - Likely pathogenic |
Whiley et al., 2011 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
0.95 |
2.58 |
- |
- |
- |
2.45 |
- |
BRCA1_00126 |
14 |
c.4484G>A |
4603G>A |
p.R1495K |
0.164812191 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
- |
0.4 |
0.897288675 |
1.067279157 |
- |
0.383063 |
- |
BRCA1_00223 |
14 |
c.4484G>C |
4603G>C |
p.R1495T |
0.993039479 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.02 |
0.34 |
0.02 |
0.34 |
27.7342 |
9.9856 |
- |
- |
- |
276.9426275 |
- |
BRCA1_00271 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
14 |
c.4484G>T |
4603G>T |
p.R1495M |
1.00000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
0.02 |
0.34 |
0.00 |
0.34 |
1 |
- |
1.91E+05 |
6.46 |
- |
1.23E+06 |
- |
BRCA1_00154 |
14 |
c.4484+1del |
IVS14+1del |
- |
0.996657082 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.97 |
0.32770636 |
28.13744896 |
- |
- |
- |
9.220820978 |
- |
BRCA1_00482 |
14 |
c.4484+10A>G |
IVS14+10A>G |
- |
0.00135712 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
- |
0.02 |
0.02 |
- |
- |
0.064456265 |
1.033092037 |
- |
0.066589254 |
- |
BRCA1_00481 |
14 |
c.4485-18T>A |
IVS14-18T>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
1.613622932 |
1.033092037 |
- |
1.667021002 |
- |
BRCA1_00485 |
14 |
c.4485-8C>T |
IVS14-8C>T |
- |
0.013290971 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
0.3592 |
0.9 |
- |
- |
- |
0.32328 |
- |
BRCA1_00488 |
14 |
c.4485-2A>G |
IVS14-2A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
0.640829534 |
1.297514181 |
- |
0.831485408 |
- |
BRCA1_00487 |
14 |
c.4485-1G>T |
IVS14-1G>T |
- |
0.99746182 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
11.76479319 |
1.033092037 |
- |
12.15411416 |
- |
BRCA1_00486 |
15 |
c.4520G>C |
4639G>C |
p.R1507T |
0.000442268 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.21 |
0.090635439 |
1.1390848 |
- |
0.021680705 |
- |
BRCA1_00489 |
15 |
c.4534A>T |
4653A>T |
p.S1512G |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.914806725 |
1.033092037 |
- |
0.945079543 |
- |
BRCA1_00490 |
15 |
c.4535G>T |
4654G>T |
p.S1512I |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
<1e-10 |
- |
<1e-10 |
- |
BRCA1_00016 |
15 |
c.4549C>T |
4668C>T |
p.L1517V |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.779710926 |
1.067279157 |
- |
0.83216922 |
- |
BRCA1_00491 |
15 |
c.4565A>G |
4684A>G |
p.Y1522C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.27958483 |
1.033092037 |
- |
1.321928898 |
- |
BRCA1_00493 |
15 |
c.4571C>T |
4690C>T |
p.S1524C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.1815 |
0.49 |
- |
- |
- |
0.578935 |
- |
BRCA1_00494 |
15 |
c.4585A>G |
4704A>G |
p.I1529V |
0.007617415 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.289876122 |
1.297514181 |
- |
0.37611838 |
- |
BRCA1_00495 |
15 |
c.4600G>A |
4719G>A |
p.V1534M |
0.00010 |
1 - Not pathogenic or of no clinical significance |
Chenevix-Trench et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.0086 |
0.139 |
- |
4.02 |
- |
0.00481 |
- |
BRCA1_00029 |
15 |
c.4625C>G |
4744C>G |
p.S1542C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
4.0156 |
0.49 |
- |
- |
- |
1.967644 |
- |
BRCA1_00496 |
15 |
c.4631C>T |
4750C>T |
p.P1544R |
0.005294773 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.21 |
1.202238751 |
1.033092037 |
- |
0.260824889 |
- |
BRCA1_00497 |
15 |
c.4636G>A |
4755G>A |
p.D1546N |
0.00011 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
5.60E-03 |
- |
0.0056 |
- |
BRCA1_00022 |
15 |
c.4636G>T |
4755G>T |
p.D1546Y |
0.00002 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
1 |
- |
0.275 |
0.00339 |
- |
0.00093 |
- |
BRCA1_00088 |
15 |
c.4649C>T |
4768C>T |
p.T1550R |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.059460886 |
1.255952165 |
- |
1.330632194 |
- |
BRCA1_00498 |
15 |
c.4657T>A |
4776T>A |
p.L1553V |
0.009860517 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.42839395 |
1.1390848 |
- |
0.487977036 |
- |
BRCA1_00499 |
15 |
c.4675G>A |
4794G>A |
p.E1559K |
0.996070077 |
5 - Pathogenic |
Parsons et al 2019 |
- |
0.02 |
0.97 |
0.02 |
0.97 |
1.791383082 |
- |
3.484125209 |
1.255952165 |
- |
7.838903556 |
- |
BRCA1_00404 |
15 |
c.4675+1G>A |
IVS15+1G>A |
- |
1.000 |
5 - Definitely pathogenic |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.97 |
0.00 |
0.97 |
1 |
- |
128.82 |
1.55 |
- |
199.67 |
- |
BRCA1_00127 |
15 |
c.4675+3A>T |
IVS15+3A>T |
- |
0.992883383 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
4.176717726 |
1.033092037 |
- |
4.314933824 |
- |
BRCA1_00269 |
15 |
c.4676-16C>G |
IVS15-16C>G |
- |
0.016829401 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
0.372592396 |
1.102597599 |
- |
0.410819482 |
- |
BRCA1_00502 |
|
DNA change |
|

 | |
|
|
|
|
Key Observational Reference |
 |

 | |
|
Missense analysis Prior P |
 |

 | |
|
|
|
|
|
|
|
|
|
|
|
15 |
c.4676-11A>G |
IVS15-11A>G |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.04 |
0.02 |
0.04 |
- |
- |
1.073391647 |
1.067279157 |
- |
1.145608533 |
- |
BRCA1_00501 |
15 |
c.4676-10T>A |
IVS15-10T>A |
- |
- |
- |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.925839811 |
1.067279157 |
- |
0.988129533 |
- |
BRCA1_00500 |
15 |
c.4676-8C>G |
IVS15-8C>G |
- |
0.134851272 |
3 - Uncertain |
Parsons et al 2019 |
- |
- |
0.34 |
0.02 |
0.34 |
- |
- |
0.274417782 |
1.102597599 |
- |
0.302572387 |
- |
BRCA1_00505 |
15 |
c.4676-2A>G |
IVS15-2A>G |
- |
0.987072432 |
4 - Likely Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
- |
- |
2.285823557 |
1.033092037 |
- |
2.361466115 |
- |
BRCA1_00504 |
15 |
c.4676-1G>A |
IVS15-1G>A |
- |
0.999912467 |
5 - Pathogenic |
Parsons et al 2019 |
- |
- |
0.97 |
0.02 |
0.97 |
3.7504 |
- |
32.31331637 |
2.915267271 |
- |
353.2950069 |
- |
BRCA1_00503 |
16 |
c.4676-7C>T |
IVS15-7C>T |
- |
0.000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Vallee et al. 2016 |
- |
0.04 |
0.00 |
0.04 |
0.01 |
- |
0.58 |
1.32 |
- |
8.13E-03 |
- |
BRCA1_00139 |
16 |
c.4691T>C |
4810T>C |
p.L1564P |
0.00007 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
3.30E-03 |
- |
0.0033 |
- |
BRCA1_00023 |
16 |
c.4702A>G |
4821A>G |
p.I1568V |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
1.537780316 |
1.067279157 |
- |
1.64124088 |
- |
BRCA1_00507 |
16 |
c.4726G>C |
4845G>C |
p.E1576Q |
0.009453202 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.452648414 |
1.033092037 |
- |
0.467627473 |
- |
BRCA1_00508 |
16 |
c.4729T>C |
4848T>C |
p.S1577P |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
1.2234 |
- |
0.501222026 |
1.297514181 |
- |
0.795629244 |
- |
BRCA1_00509 |
16 |
c.4730C>A |
4849C>A |
p.S1577Y |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.64 |
0.914806725 |
1.067279157 |
- |
0.624866656 |
- |
BRCA1_00510 |
16 |
c.4733A>G |
4852A>G |
p.D1578G |
0.010070867 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.482525023 |
1.033092037 |
- |
0.498492759 |
- |
BRCA1_00511 |
16 |
c.4739C>T |
4858C>T |
p.S1580C |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.619189858 |
1.067279157 |
- |
0.66084843 |
- |
BRCA1_00512 |
16 |
c.4765C>T |
4884C>T |
p.R1589G |
0.002439128 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.21 |
0.469286282 |
1.215721465 |
- |
0.119809495 |
- |
BRCA1_00513 |
16 |
c.4766G>A |
4885G>A |
p.R1589H |
0.006373364 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.64 |
0.417317436 |
1.176779436 |
- |
0.314297969 |
- |
BRCA1_00688 |
16 |
c.4771G>A |
4890G>A |
p.G1591S |
- |
- |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.492108355 |
1.033092037 |
- |
0.508393223 |
- |
BRCA1_00514 |
16 |
c.4776C>A |
4895C>A |
p.N1592K |
0.004058999 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.193304679 |
1.033092037 |
- |
0.199701524 |
- |
BRCA1_00515 |
16 |
c.4811A>G |
4930A>G |
p.Q1604R |
0.050468364 |
3 - Uncertain |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
2.440213563 |
1.067279157 |
- |
2.604389075 |
- |
BRCA1_00517 |
16 |
c.4814T>C |
4933T>C |
p.L1605S |
0.005305792 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
- |
0.252998366 |
1.033092037 |
- |
0.261370597 |
- |
BRCA1_00518 |
16 |
c.4816A>G |
4935A>G |
p.K1606E |
0.000265668 |
1 - Not pathogenic or of no clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
0.081900008 |
- |
0.114809233 |
1.384809842 |
- |
0.013021197 |
- |
BRCA1_00519 |
16 |
c.4837A>G |
4956A>G |
p.S1613G |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
<1e-10 |
- |
<1e-10 |
- |
BRCA1_00012 |
16 |
c.4840C>T |
4959C>T |
p.P1614S |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Easton et al. 2007 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
0.0955 |
- |
0.309 |
7.59E-08 |
- |
2.23977E-9 |
- |
BRCA1_00089 |
16 |
c.4868C>G |
4987C>G |
p.A1623G |
0.9986 |
5 - Definitely pathogenic |
Walker et al., 2010 |
Vallee et al. 2016 |
0.02 |
0.64 |
0.00 |
0.64 |
27.72 |
1.23 |
10.47 |
1.09 |
- |
389.1 |
- |
BRCA1_00124 |
16 |
c.4882A>G |
5001A>G |
p.M1628V |
0.006344774 |
2 - Likely not pathogenic or of little clinical significance |
Parsons et al 2019 |
- |
0.02 |
- |
0.02 |
0.02 |
- |
0.59 |
0.370676733 |
1.430636021 |
- |
0.312879057 |
- |
BRCA1_00689 |
16 |
c.4883T>C |
5002T>C |
p.M1628T |
0.00000 |
1 - Not pathogenic or of no clinical significance |
Tavtigian et al. 2006 |
Tavtigian et al. 2008 |
0.02 |
0.01 |
0.00 |
0.02 |
- |
- |
- |
1.60E-04 |
- |
0.00016 |
- |
BRCA1_00013 |